SCHEMBL5103155

SCHEMBL5103155

FC(F)(F)c1cccc(C[Zn])c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.64
IDO1 P14902 2/20 0.62
HTR2A P28223 2/20 0.60
HTR2B P41595 2/20 0.60
HTR2C P28335 1/20 0.60
ACP3 P15309 1/20 0.58
MIF P14174 2/20 0.56
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
GAA P10253 1/20 0.55
GRIN2B Q13224 1/20 0.53
TSHR P16473 1/20 0.52
MAPK1 P28482 1/20 0.52
MAOB P27338 3/20 0.51
LMNA P02545 2/20 0.51
MAPT P10636 2/20 0.51
SIGMAR1 Q99720 1/20 0.51
ADRA2C P18825 1/20 0.51
SLC6A4 P31645 1/20 0.51
ADRA1A P35348 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3602086 0.98 TAAR1 (0.62) TAAR1IDO1HTR2AHTR2BHTR2C
Hydrochloric Acid SCHEMBL2124663 0.98 IDO1 (0.63) TAAR1IDO1HTR2AHTR2BHTR2C
SCHEMBL2093444 0.86 TAAR1 (0.60) TAAR1IDO1HTR2AHTR2BHTR2C
SCHEMBL3237564 0.86 TAAR1 (0.64) TAAR1IDO1HTR2AHTR2BHTR2C
SCHEMBL46757 0.84 HTR2A (0.63) TAAR1IDO1HTR2AHTR2BHTR2C
SCHEMBL3643679 0.84 TAAR1 (0.62) TAAR1IDO1HTR2AHTR2BHTR2C
Pivalate SCHEMBL9952824 0.84 ACP3 (0.53) TAAR1IDO1HTR2AHTR2BHTR2C
SCHEMBL41778 0.82 TAAR1 (0.60) TAAR1IDO1HTR2AHTR2BHTR2C
SCHEMBL7452386 0.82 TAAR1 (0.60) TAAR1IDO1HTR2AHTR2BHTR2C
SCHEMBL14423479 0.82 TAAR1 (0.60) TAAR1IDO1HTR2AHTR2BHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108174603-B 1-heteroaryl-indoline-4-carboxamides as GPR52 modulators 阿芮纳制药有限公司 2021-07-02 CN disclosed
US-20080021026-A1 BENZOTHIOPHENE INHIBITORS OF RHO KINASE Kahraman, Mehmet (US) 2008-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021026-A1 BENZOTHIOPHENE INHIBITORS OF RHO KINASE RHOT2, ROCK2, ROCK1 TAAR1 4416/4885IDO1 3541/4885HTR2A 4048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.